Drug treatment for resistant depression

descriptionPublicationkeyboard_double_arrow_right Article 01 Apr 2000 English Publisher:Royal College of PsychiatristsJournal:British Journal of Psychiatry, volume 176, pages 398-398 (issn: 0007-1250, eissn: 1472-1465,

Copyright policy )

Authors: S, Daniels;

doi: 10.1192/bjp.176.4.398

pmid: 10827893

Drug treatment for resistant depression

- Summary
- Subjects
- Metrics

Abstract

On the basis of a four-week study carried out in 122 patients suffering from treatment-resistant depression, Poirier & Boyer ([1999][1]) claimed that “ venlafaxine showed some evidence of superiority to paroxetine in this difficult-to-treat population”. Careful analysis of their results, however

Keywords

Paroxetine, Bias, Mental Disorders, Drug Resistance, Venlafaxine Hydrochloride, Humans, Cyclohexanols, Selective Serotonin Reuptake Inhibitors

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average